To investigate cell-specific alterations in FTD triggered by mutations in the CHMP2B gene, we generated a hESC line carrying the previously described intron 5 mutation4 in heterozygosis, as it is found in patients for being a dominant mutation, using CRISPR/Cas9 genome editing. Here, CHMP2B is linked to frontotemporal dementia.